DENNIS VILLAREAL to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications DENNIS VILLAREAL has written about Diabetes Mellitus, Type 2.
Connection Strength
2.019
-
Should the Incretin hype be the same for older adults: Promise + cautions. J Am Geriatr Soc. 2024 Jul; 72(7):2266-2268.
Score: 0.459
-
Lifestyle Intervention Strategy to Treat Diabetes in Older Adults: A Randomized Controlled Trial. Diabetes Care. 2022 09 01; 45(9):1943-1952.
Score: 0.414
-
Weight loss and improved fitness slow down the decline in mobility in obese adults with type 2 diabetes. Evid Based Med. 2013 Apr; 18(2):e18.
Score: 0.205
-
TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action. Diabetes. 2010 Feb; 59(2):479-85.
Score: 0.171
-
Circulating osteogenic progenitors and osteoclast precursors are associated with long-term glycemic control, sex steroids, and visceral adipose tissue in men with type 2 diabetes mellitus. Front Endocrinol (Lausanne). 2022; 13:936159.
Score: 0.104
-
One-Year Mean A1c of?>?7% is Associated with Poor Bone Microarchitecture and Strength in Men with Type 2 Diabetes Mellitus. Calcif Tissue Int. 2022 09; 111(3):267-278.
Score: 0.102
-
Hemoglobin A1c Threshold for Reduction in Bone Turnover in Men With Type 2 Diabetes Mellitus. Front Endocrinol (Lausanne). 2021; 12:788107.
Score: 0.099
-
Testosterone Therapy Effects on Bone Mass and Turnover in Hypogonadal Men with Type 2 Diabetes. J Clin Endocrinol Metab. 2021 07 13; 106(8):e3058-e3068.
Score: 0.096
-
In Men With Obesity, T2DM Is Associated With Poor Trabecular Microarchitecture and Bone Strength and Low Bone Turnover. J Clin Endocrinol Metab. 2021 04 23; 106(5):1362-1376.
Score: 0.094
-
Hypogonadal men with type 2 diabetes mellitus have smaller bone size and lower bone turnover. Bone. 2017 06; 99:14-19.
Score: 0.071
-
Circulating cytokines as determinants of weight loss-induced improvements in insulin sensitivity. Endocrine. 2017 Jan; 55(1):153-164.
Score: 0.068
-
Xenin-25 amplifies GIP-mediated insulin secretion in humans with normal and impaired glucose tolerance but not type 2 diabetes. Diabetes. 2012 Jul; 61(7):1793-800.
Score: 0.051
-
Weight loss therapy improves pancreatic endocrine function in obese older adults. Obesity (Silver Spring). 2008 Jun; 16(6):1349-54.
Score: 0.038
-
Health implications of racial differences in serum growth differentiation factor levels among men with obesity. Physiol Rep. 2024 Dec; 12(23):e70124.
Score: 0.030
-
Sarcopenia Trials in Specific Diseases: Report by the International Conference on Frailty and Sarcopenia Research Task Force. J Frailty Aging. 2016; 5(4):194-200.
Score: 0.016